ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

BDTX Black Diamond Therapeutics Inc

6,82
0,23 (3,49%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Black Diamond Therapeutics Inc BDTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,23 3,49% 6,82 06:00:08
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,67 6,60 7,14 6,96 6,59
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202422:05GLOBEBlack Diamond Therapeutics Announces Presentations at the..
11.4.202414:00GLOBEBlack Diamond Therapeutics Announces Changes to Board of..
08.4.202400:00GLOBEBlack Diamond Therapeutics Presents Novel Real-World..
03.4.202414:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
12.3.202413:00GLOBEBlack Diamond Therapeutics Reports Fourth Quarter and Full..
11.3.202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.3.202422:30GLOBEBlack Diamond Therapeutics Announces Upcoming Presentation..
28.2.202414:00GLOBEBlack Diamond Therapeutics to Participate in the TD Cowen..
15.2.202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202422:04EDGAR2Form 8-K - Current report
04.1.202414:07EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEBlack Diamond Therapeutics Announces Corporate Update and..
13.12.202313:08EDGAR2Form 8-K - Current report
13.12.202313:00GLOBEBlack Diamond Therapeutics Announces Topline Results from..
07.11.202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
06.11.202313:45GLOBEBlack Diamond Therapeutics Reports Third Quarter 2023..
06.11.202313:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202313:10EDGAR2Form 8-K - Current report
14.10.202318:30GLOBEBlack Diamond Therapeutics Presents Dose Escalation Data..
04.10.202318:14GLOBEBlack Diamond Therapeutics to Present Preclinical and..
18.9.202323:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202313:12EDGAR2Form 8-K - Current report
18.9.202313:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
11.9.202314:00GLOBEBlack Diamond Therapeutics Announces First Patients Dosed in..
05.9.202314:00GLOBEBlack Diamond Therapeutics to Participate in Upcoming..
11.8.202313:30GLOBEBlack Diamond Therapeutics Reports Second Quarter 2023..
11.8.202313:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202313:22EDGAR2Form 8-K - Current report
30.6.202322:03EDGAR2Form 8-K - Current report
30.6.202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30.6.202302:57GLOBEBlack Diamond Therapeutics Announces Pricing of Public..
29.6.202312:02EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28.6.202322:23GLOBEBlack Diamond Therapeutics Announces Proposed Public..
27.6.202313:00GLOBEBlack Diamond Therapeutics Announces Initial Dose Escalation..
13.6.202314:00GLOBEBlack Diamond Therapeutics Announces Promotion of Melanie..
02.6.202314:00GLOBEBlack Diamond Therapeutics to Present at the Jefferies..
09.5.202313:30GLOBEBlack Diamond Therapeutics Reports First Quarter 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock